(Q57111224)
Statements
Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation (English)
Martí F
Pardo N
Peiró M
Amill B
García J
Cubells J
1 December 1995